THE MIKAN GROUP is an Advisory Services Business focused on supporting Emerging Businesses. The partners of THE MIKAN GROUP have a long, successful, and storied history working together as the senior management team at MEDRAD Inc., the global leader in medical imaging technologies that is now part of Bayer HealthCare. This team was instrumental in building MEDRAD from an emerging start-up to a near billion-dollar company with a 70% market leadership position in its core business. THE MIKAN GROUP provides services to businesses in the Life Science, Medical Device, & Healthcare sectors. Our focus is to provide our customers with business analysis, launch, commercialization management and action orientated business consulting. Capability Overview: • Broad global business expertise with members based in North America, Europe, Middle East, and Asia. • Our National Baldrige Quality Award winning management team can provide Organizational Design improvement and Performance Excellence deployment. • Extensive Medical Device business knowledge and Commercialization expertise in all major global markets. • Experience in developing growth strategies for new products, new markets, and new territories. • Extensive Strategic and Business Planning capabilities. • Global Distribution Analysis know-how. • Extensive experience building and implementing Post-Sales Customer Success programs. • Solutions for New Companies, New Products, and New Regional Launches customized to the specific requirements of each client and each project. • Tailored Commercialization programs: PIVOT PATH, LAUNCH PATH, FOSTER PATH • Approach customized to each business case including timing appropriate to business goals and flexible payment options to accommodate budget constraints. OUR GLOBAL TEAM: - Michael Bobrove - Japan - Peter Cléber – The Netherlands - John Friel – Pittsburgh, USA - Denis Olson – Pittsburgh, USA - Carmen Serfezi – Cyprus - John Tedeschi – San Diego, USA
